Stephen Haworth
Direttore Tecnico/Scientifico/R&S presso XORTX THERAPEUTICS INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Stephen Haworth
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| XORTX THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2021 | - |
Storia della carriera di Stephen Haworth
Precedenti posizioni note di Stephen Haworth
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CORMEDIX INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2017 | 01/01/2018 |
Elusys Therapeutics, Inc.
 Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Direttore Tecnico/Scientifico/R&S | 01/03/2012 | 01/04/2013 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 01/04/2015 | 01/04/2016 |
Formazione di Stephen Haworth
| UCL Medical School | Doctorate Degree |
| University College London | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Regno Unito | 3 |
| Canada | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| XORTX THERAPEUTICS INC. | Health Technology |
| CORMEDIX INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Elusys Therapeutics, Inc.
Elusys Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elusys Therapeutics, Inc. develops antibody therapies. It is engaged in development Anthim (oblitoxaximab) a mAb anthrax antitoxin for the treatment and prevention of inhalational anthrax used in a bioterror attack. The company was founded in May 1998 and is headquartered in Pine Brook, NJ. | Health Technology |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
- Borsa valori
- Insiders
- Stephen Haworth
- Esperienza
